Panel Discussion and Vote

Sunday, March 9, 2025

8:53 AM - 9:05 AM ET

Panel Moderator(s)

Brian C. Case, MD

Interventional Cardiologist; Assistant Professor of Medicine, Georgetown University; Director of Cath Lab, Chief of Interventional Cardiology, MedStar Southern Maryland Hospital
MedStar Heart and Vascular Institute
Bethesda, Maryland, United States

No relationships to disclose
Dionne P. Ross, MSN, RN, NE-BC

Nursing Director
MedStar Washington Hospital Center
Washington, District of Columbia, United States

No relationships to disclose

Panel Discussant(s)

Ryan D. Madder, MD

Section Chief of Interventional Cardiology & Director of Cardiac Cath Lab
Corewell Health
Ada, Michigan, United States

No relationships to disclose
Sa'ar Minha, MD

Director, Interventional Cardiology
Shamir Medical Center
Shoham, Israel

Disclosure(s): Abbott Vascular, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Arnold H. Seto, MD, MPA

Director of Cardiac Cath Lab
Long Beach Veterans Affairs Medical Center
Long Beach, California, United States

Disclosure information not submitted.
Julie Straface, MS, PA-C

Interventional Cardiology Physician Assistant
New York Presbyterian Hudson Valley Hospital
Cortland Manor, New York, United States

Disclosure(s): No financial relationships to disclose

Disclosure(s):

Katie Beaudoin, CRNP- BC: No financial relationships to disclose

Brian C. Case, MD: Acist Medical: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Philips Medical Systems, Inc.: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Dionne P. Ross, MSN, RN, NE-BC: No financial relationships to disclose

Ryan D. Madder, MD: Abbott Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Angiowave Imaging: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Boston Scientific: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Corindus: Grant/Research Support (Terminated), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Gentuity: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); Microbot Medical: Grant/Research Support (Ongoing); Nanoflex Robotics: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); RapidAI: Consulting Fees (e.g., advisory boards) (Ongoing); Spectrawave: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing)

Sa'ar Minha, MD: Abbott Vascular, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

David G. Rizik, MD, MSCAI, FACC: No financial relationships to disclose

Arnold H. Seto, MD, MPA: Frond Medical: Consultant (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); GE Healthcare: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Maquet Getinge Group: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Summacor: Consultant (Ongoing), Stock-privately held company (Ongoing)

Julie Straface, MS, PA-C: No financial relationships to disclose